公司資料
Mersana Therapeutics 股價、新聞與催化劑
- 股票代碼:
- MRSN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for MRSN.
公司概覽
業務概覽
Mersana Therapeutics is an oncology company developing antibody-drug conjugates for cancer. The company’s identity is built around payload delivery and targeted tumor therapy.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Mersana sits in oncology biotechnology.
商業模式特徵
Its business depends on clinical data, platform differentiation, and the ability to turn ADC science into a commercial story.
生技產業定位
Mersana is a classic ADC catalyst name where efficacy and tolerability can quickly change sentiment.
未來催化劑
- Mersana's catalysts are its ADC programs, especially XMT-1660 and XMT-2056, where any clean data can change the tone quickly. The company is still very much a data story.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。